What is GTBP stock price today?

Visit our real-time dashboard for the current GTBP stock price and live market data.

Is GTBP stock going up or down today?

GTBP stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy GTBP stock now?

The decision to buy GTBP depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is GTBP a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for GTBP based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is GTBP stock overvalued or undervalued?

Use our DCF valuation calculator to determine if GTBP is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is GTBP's P/E ratio?

P/E ratio data for GTBP will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is GTBP's market cap?

GTBP (GT Biopharma Inc) has a market capitalization of $0.02 billion, making it a small-cap stock.

What is GTBP's price to book ratio?

GTBP trades at a price-to-book (P/B) ratio of 2.12, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does GTBP pay dividends?

GTBP does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is GTBP's dividend yield?

GTBP does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is GTBP stock a good long-term investment?

GTBP's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is GTBP's revenue growth rate?

Revenue growth data for GTBP is available on our dashboard with detailed financial statement analysis.

Profitability metrics for GTBP are available on our dashboard with complete income statement analysis.

What are the risks of investing in GTBP?

Key risks for GTBP include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does GTBP compare to its competitors?

Compare GTBP to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize GTBP's performance and positioning.

What is GTBP's stock price target for 2026?

Visit our prediction page for AI-powered price targets for GTBP with bull, base, and bear case scenarios.

What do analysts say about GTBP?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for GTBP. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is GTBP's next earnings report?

GTBP reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

GTBP - GT Biopharma Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About GT Biopharma Inc

GT Biopharma Inc (GTBP) common stock

Price Chart

Loading chart...

GTBP Key Statistics

Market Cap

$17.43M

P/B Ratio

2.12

How GTBP Compares to Peers

GTBP is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
GTBP(This stock)	$17.43M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 23, 2026 at 6:59 PM EDT

Ready to invest in GTBP?

Commission-free trading available. Affiliate links.

GTBP Lician Score

5% confidence

4.0/10

Neutral

GTBP has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates GTBPacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

GTBP Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for GTBP

Dashboard

Enter a ticker to analyze